Dot I/O Health is a consultancy and data analytics company which provides next generation solutions to ensure the pharmaceutical industry can make sense of their market to improve decision making. Information overload, rapidly changing markets and uncertain times have lead to business leaders struggling to see a clear route ahead. Founded in 2015 our solutions have helped clients in some of the largest and most progressive pharmaceutical companies solve these challenges and connect the dots.
The DEEP data forensics approach is the solution which ensures you can make sense of all of your data to improve decision making. We use sophisticated AI tools to collect and categorise vast amounts of your data which can include market reports, internal decks, ad-board reports, databases and even one-on-one interviews led by us. Our experts then connect the dots with the DEEP framework to extract the key data and insights based on your business questions. Customised to your needs we then use powerful data visualisation, storytelling and dashboards to ensure your team is fully up to speed.
Sometimes you don't have the data. Our DEEP Horizon approach is faster, better quality and delivers more cost efficiencies than traditional approaches. We use data science and AI to unlock online and social media data, complemented with our on the ground investigative team who get the inside stories. Our next generation solution is the answer to modern day research, providing the situational awareness today and anticipating what comes tomorrow.
In a complex world, the breadth and depth of data required by teams to effectively create robust plans for market access is challenging. Using our DEEP solutions we meticulously scour through every piece of data to build an understanding of the local market or region. Connecting the dots and building a complete view of the situation, from the big picture down to the small detail. Our consulting team will then work closely to develop a strategy and implement a plan. We have a proven track record in improving reimbursement outcomes including reversing negative decisions.
Emerging markets can be difficult to navigate. Traditional data can be scarce or incomplete. Thats why we have become the go to solution for many of the worlds biggest pharma companies who trust our approach. In the last 2 years we have worked across 45 emerging markets including, Asia, S. America, the M.E and E. Europe analysing the market in its native language.
We work with business unit leaders and strategic planners to optimise decision making, scenario plan and ensure no gaps exist in their knowledge. We advise across the development lifecycle including early assets, pre-market and the launch phase. With a growing reputation for providing disruptive thinking.
Our team consists of seasoned leaders in communication enhanced by creatives thinkers and on-staff investigative journalists, to ensure brand and corporate messaging with game changing potential. Our brand messaging is developed by our data analysis techniques which measures how a particular message will resonate with its audience.
NASH is set to become one of the worlds biggest health challenges. Using our DEEP data science AI we have developed the worlds most complete real-time NASH data universe, which allows us to answer any question on this wide-ranging disease. For the last three years we have been working with pharmaceutical companies in this space, providing their leadership with real-time analysis, insight and strategy.
